Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity
Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx’s customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications.
The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact.